Cyclosporiasis and Microsporidiosis: Diagnostic Challenges and Molecular Detection
Food-borne and waterborne intestinal infections caused by protozoa Cyclospora cayetanensis and fungal Microsporidia species (E. bieneusi, E. intestinalis, E. hellem, and E. cuniculi), require rapid diagnosis to support targeted treatments and public health interventions. A multiplex PCR assay like the BioGX Cyclospora cayetanensis and Microsporidia assay for the BD MAXTM can identify the Cyclospora cayetanensis and screen for the Encephalitozoon cuniculi, Encephalitozoon hellem, Encephalitozoon intestinalis and Enterocytozoon bieneusi members of the Microsporidia phyla.
A brief overview of clinical manifestations and testing approaches are defined below to highlight the importance of rapid real-time PCR diagnostics of suspected cases of Cyclosporiasis and Microsporidiosis. Speed of diagnosis allows for effective clinical management and supports regional surveillance efforts.
Diagnostic Strategies
Cyclosporiasis
Cyclospora cayetanensis
Cyclospora cayetanensis infections are primarily associated with the consumption of contaminated food or water. Recent outbreaks have been centered around the Great Lakes region in the United States and Canada. Clinical manifestations include watery diarrhea, loss of appetite, weight loss, cramping, nausea, and fatigue. To prevent prolonged illness and support public health surveillance, rapid testing improves patient outcomes.1
Current diagnostic tests for Cyclospora cayetanensis:
- PCR of stool specimens or extracted samples
- Microscopy with special acid-fast stains
- Molecular surveillance
Microsporidiosis
Microsporidia species
Microsporidia infections often lead to progressive intestinal or systemic disease amongst immunocompromised individuals and organ transplant recipients. The PCR assay targets a specific panel including Enterocytozoon bieneusi, Encephalitozoon intestinalis, and other major pathogens. Clinical manifestations typically include chronic diarrhea and wasting syndrome, particularly in vulnerable populations. Rapid molecular detection is essential for effective use of anti-parasitic drugs.2,3
Current diagnostic tests for Microsporidia:
- PCR of stool or biopsy samples
- Histopathology with specialized stains
- Immunofluorescence assays
Why PCR-based testing stands out
Detecting Cyclospora presents significant diagnostic challenges due to intermittent shedding and typically low oocyst concentrations in clinical samples. Because many traditional parasite panels do not routinely screen for this pathogen, standard ova-and-parasite examinations often fail to yield reliable results. While microscopy remains an option, it necessitates extensive labor, specialized laboratory expertise for staining and concentration, and subjective interpretation; furthermore, identifying oocysts may require the collection of multiple stool specimens. Consequently, the CDC advises healthcare providers to specifically order Cyclospora testing and recommends the adoption of molecular PCR-based methodologies to improve detection sensitivity.
References
- Ortega, Ynés R., and Roxana Sanchez. 2010. Update on Cyclospora cayetanensis, a food-borne and waterborne parasite. Clinical Microbiology Reviews 23.1: 218-234.
- Verweij, Jaco J., et al. 2007. Multiplex detection of Enterocytozoon bieneusi and Encephalitozoon spp. in fecal samples using real-time PCR. Diagnostic microbiology and infectious disease 57.2: 163-167.
- Wolk, D. M., et al. 2002. Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens. Journal of clinical microbiology 40.11: 3922-3928.
- Clinical Guidance for Cyclosporiasis. 2024. Centre for Disease Control and Prevention (CDC). https://www.cdc.gov/cyclosporiasis/hcp/clinical-guidance/index.html
Disclaimer: Information in this blog is provided for educational and informational purposes only. It is not intended to provide diagnostic or treatment recommendations. Readers are encouraged to consult appropriate scientific and public health sources.
